scholarly journals Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010–2015

2017 ◽  
Vol 66 (2) ◽  
pp. 185-190 ◽  
Author(s):  
Katie J Suda ◽  
Lauri A Hicks ◽  
Rebecca M Roberts ◽  
Robert J Hunkler ◽  
Linda M Matusiak ◽  
...  
Keyword(s):  
United States ◽  
Healthcare Setting ◽  
The United States ◽  
Medication Class

scholarly journals Antibiotic Expenditures by Medication Class and Healthcare Setting in the United States, 2010–2013

2015 ◽  
Vol 2 (suppl_1) ◽  
Author(s):  
Katie Suda ◽  
Lauri Hicks ◽  
Rebecca M. Roberts ◽  
Robert Hunkler ◽  
Linda Matusiak ◽  
...  
Keyword(s):  
United States ◽  
Healthcare Setting ◽  
The United States ◽  
Medication Class

scholarly journals A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009

2012 ◽  
Vol 68 (3) ◽  
pp. 715-718 ◽  
Author(s):  
K. J. Suda ◽  
L. A. Hicks ◽  
R. M. Roberts ◽  
R. J. Hunkler ◽  
L. H. Danziger
Keyword(s):  
United States ◽  
Healthcare Setting ◽  
The United States

scholarly journals The Ecology of Antihypertensives in the United States, 1997-2017

2020 ◽  
Author(s):  
Michael E. Johansen ◽  
Joshua D. Niforatos ◽  
Jeremey B. Sussman
Keyword(s):  
United States ◽  
Beta Blocker ◽  
Medical Expenditure Panel Survey ◽  
The United States ◽  
Medical Expenditure ◽  
Future Research ◽  
Channel Blockers ◽  
Converting Enzyme Inhibitors ◽  
Cross Sectional ◽  
Medication Class

AbstractBackgroundAntihypertensives are the most used medication type in the United States, yet there remains uncertainty about the use of different antihypertensives. We sought to characterize use of antihypertensives by and within medication class(es) between 1997-2017.MethodsA repeated cross-sectional study of 493,596 adult individuals using the 1997-2017 Medical Expenditure Panel Survey (MEPS). The Orange Book and published research were used for adjunctive information. The primary outcome was the estimated use by and within anti-hypertensive medication class(es).ResultsThe proportion of individuals taking any antihypertensive during a year increased from 1997 to the early 2010’s and then remained stable. The proportion of the population taking 2 or more medications declined from 2015-2017. The proportion of adults using angiotensin II receptor-blockers (ARBs) and dihydropyridine calcium channel-blockers (CCBs) increased during the study period, while angiotensin-converting enzyme inhibitors (ACE-Is) increased until 2010 after which rates remained stable. Beta-blocker use was similar to ACE-Is with an earlier decline starting in 2012. Thiazide diuretic use increased from 1997-2007, leveled off until 2014, and declined from 2015-2017. Non-dihydropyridine CCBs use declined throughout the study. ACE-Is, ARBs, CCBs, thiazide diuretics, and loop diuretics all had one dominant in-class medication. There was a clear increase in the use of losartan within ARBs, lisinopril within ACE-Is, and amlodipine within CCBs following generic conversion. Furosemide and hydrochlorothiazide started with and maintained a dominant position in their classes. Metoprolol use increased throughout the study and became the dominant beta-blocker, while atenolol peaked around 2005 and then declined thereafter.ConclusionsAntihypertensive classes appear to have a propensity to equilibrate to an individual medication, despite a lack of outcomes based research to compare medications within a class. Future research could focus on comparative effectiveness for within-class medications early in the life cycle of therapeutics that are probable to have wide spread use.

What Do Women Want? Consent for the Use of Electronic Fetal Monitoring

2021 ◽  
Vol 11 (3) ◽  
pp. 145-153
Author(s):  
Sonya Dal Cin ◽  
Lisa Kane Low ◽  
Denise Lillvis ◽  
Megan Masten ◽  
Raymond De Vries
Keyword(s):  
United States ◽  
Healthcare Providers ◽  
Fetal Monitoring ◽  
Healthcare Setting ◽  
Professional Associations ◽  
The United States ◽  
Cesarean Birth ◽  
Electronic Fetal Monitoring ◽  
Risk Patients

BACKGROUNDGuidelines published by professional associations of midwives, obstetricians, and nurses in the United States recommend against using continuous cardiotocography (CTG) in low-risk patients. In the United States, CTG or electronic fetal/uterine monitoring (EFM) rather than auscultation with a fetoscope or Pinard horn is the norm. Interpretation of the fetal heart rate (FHR) and uterine activity (UA) tracings provided by continuous EFM may be associated with the decision for a cesarean birth. Typically, consent is not sought in the decision about type of monitoring. No studies were identified where women's attitudes about the need to consent to the type of fetal monitoring used during labor have been explored. Therefore, the purpose of this research was to examine women's attitudes about the use of EFM in a healthcare setting.METHODSWe asked a sample of women aged 18–50 years to respond to one of three monitoringscenarios. The scenarios were used to distinguish between attitudes about monitoring in general, monitoring the health of a mother in labor, and monitoring the health of the fetus during labor. Wemeasured their level of interest in being monitored and their opinions about whether healthcare providers should be required to obtain consent for the monitoring described in the scenario.RESULTSInterest in receiving monitoring (across all three scenarios) was moderate, with the highest level of interest in monitoring the fetus during labor and the least interest in monitoring a general health context. Across all scenarios, 82% of respondents believed that practitioners should obtain consent for monitoring, 14% were unsure, and 4% said there should not be a requirement for consent. While low (6%), the percentage responding that consent was not needed was highest in monitoring a fetus in labor.CONCLUSIONSWomen in our study expressed a strong preference for the opportunity to consent to the use of monitoring regardless of the healthcare scenario. There is findings suggest the need for further research exploring what women do and do not know about CTG and what their informed performance are a pressing need to rethink the role of a pressing need to rethink the role of shared decision-making and informed consent about the type of monitoring use during labor.

scholarly journals 731. The Emergence of Mobile Colistin Resistance (mcr) Genes among Enteric Pathogens in the United States — 2008–2019

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S416-S416
Author(s):  
Farrell A Tobolowsky ◽  
Cindy R Friedman ◽  
Matthew Ryan ◽  
Meseret Birhane ◽  
Jessica Chen ◽  
...  
Keyword(s):  
United States ◽  
Healthcare Setting ◽  
The United States ◽  
Multidrug Resistant ◽  
Enteric Pathogens ◽  
Urgent Care ◽  
Emergency Rooms ◽  
Colistin Resistance ◽  
E Coli ◽  
Bacterial Sources

Abstract Background Colistin, once seldom used clinically, has resurged as a “last resort antibiotic” for multidrug-resistant infections and is still used in animal agriculture in countries outside the United States. During 2015–2018, 8 plasmid-mediated, mobile colistin resistance genes (mcr-1 to mcr-8) were each found in one or more clinical, animal, food, and environmental bacterial sources. We describe the epidemiology of mcr genes in enteric pathogens from US patients. Methods State public health laboratories have performed whole-genome sequencing on enteric bacterial pathogens since 2015, and some have sequenced older isolates. We screened sequences of isolates collected through 2019 for mcr genes using a workflow based on ResFinder 3.0. State health officials interviewed patients for clinical and epidemiologic information, including demographics, hospitalization, and travel history. Results We identified 41 patient isolates with mcr genes collected from stool, urine, and blood during 2008–2019. These included 37 nontyphoidal Salmonella (31 mcr-1, 6 mcr-3), 2 Vibrio (both mcr-4), and 2 Shiga toxin-producing E. coli (both mcr-1). The median patient age was 34 years (interquartile range: 24–54) and 54% were female. Of 23 patients with comorbidity data, 2 (9%) had immunodeficiency, 2 (9%) had past abdominal surgeries, and 1 (4%) had cancer. Patients sought care at doctor’s offices (46%), emergency rooms (35%), and urgent care clinics (19%); 24% were hospitalized for the enteric illness. None died. Among 36 with information, 35 (97%) travelled internationally in the 12 months before illness; 30 (94%) of 32 traveled in the 7 days before. Only 4 (15%) of 27 had contact with a healthcare setting during their trip; common destinations were the Dominican Republic (35%), Vietnam (24%), Thailand (15%), and China (12%). Conclusion The data strongly suggest that many patients acquired infection abroad. Nearly one in four were hospitalized, raising concerns that plasmids carrying mcr genes could spread among patients hospitalized with infections caused by multidrug-resistant pathogens for which colistin is the only available treatment. The acquisition of mcr genes by US travelers highlights the need for a global approach to antimicrobial stewardship. Disclosures All Authors: No reported disclosures

scholarly journals Drive-through Satellite Testing: An Efficient Precautionary Method of Screening Patients for SARS-CoV-2 in a Rural Healthcare Setting

2020 ◽  
Vol 11 ◽  
pp. 215013272094796
Author(s):  
Paul E. Molling ◽  
Tanner T. Holst ◽  
Benjamin G. Anderson ◽  
Kevin Fitzgerald ◽  
Megan Eddy ◽  
...  
Keyword(s):  
United States ◽  
Rural Community ◽  
Community Setting ◽  
Healthcare Setting ◽  
The United States ◽  
Community Based ◽  
Global Pandemic ◽  
Large Patient ◽  
Community Transmission ◽  
Testing Site

The first documented case of COVID-19 in the United States occurred on January 30th, 2020. Soon after, a global pandemic was declared in March 2020 with each state issuing stay at home orders based on population, risk for community transmission and current number of positive cases. A priority for each region was to develop efficient systems for testing large patient volumes in a safe manner to reduce the risk of community transmission. A community based United States health care system in the upper mid-west implemented a drive through testing site in an attempt to divert suspected cases of COVID-19 away from larger patient areas while protecting staff and patients. This commentary outlines the planning, work flow and challenges of implementing this drive through testing site in a rural community setting.

scholarly journals PDG66 METFORMIN DOSAGE PATTERNS IN TYPE 2 DIABETES PATIENTS IN A REAL-WORLD HEALTHCARE SETTING IN THE UNITED STATES

2019 ◽  
Vol 22 ◽  
pp. S173-S174
Author(s):  
R. Mahabaleshwarkar ◽  
A. DeSantis
Keyword(s):  
United States ◽  
Type 2 Diabetes ◽  
Real World ◽  
Healthcare Setting ◽  
The United States ◽  
Diabetes Patients

scholarly journals A Novel Approach for a Novel Pathogen: Using a Home Assessment Team to Evaluate Patients for COVID-19

2020 ◽  
Vol 71 (16) ◽  
pp. 2211-2214 ◽  
Author(s):  
Chloe Bryson-Cahn ◽  
Jeffrey Duchin ◽  
Vanessa A Makarewicz ◽  
Meagan Kay ◽  
Krista Rietberg ◽  
...  
Keyword(s):  
Public Health ◽  
United States ◽  
Resource Utilization ◽  
Healthcare Setting ◽  
The United States ◽  
Innovative Approach ◽  
Specimen Collection ◽  
Novel Approach

Abstract Thousands of people in the United States have required testing for SARS-CoV-2. Evaluation for a special pathogen is resource intensive. We report an innovative approach to home assessment that, in collaboration with public health, enables safe evaluation and specimen collection outside the healthcare setting, avoiding unnecessary exposures and resource utilization.

Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005–15

2017 ◽  
Vol 74 (14) ◽  
pp. 1076-1083 ◽  
Author(s):  
Margaret A. Fitzpatrick ◽  
Katie J. Suda ◽  
Charlesnika T. Evans ◽  
Robert J. Hunkler ◽  
Frances Weaver ◽  
...  
Keyword(s):  
United States ◽  
Drug Class ◽  
Healthcare Setting ◽  
The United States
Sign in / Sign up

Export Citation Format

Share Document